Background The rise of drug-resistant bacterial infections, particularly those caused by Klebsiella pneumoniae underscores the urgent need for novel therapeutic candidates. Hospital-acquired infections from K. pneumoniae carbapenemase (KPC)-producing bacteria pose a serious health threat, particularly impacting the respiratory and urinary tracts. This study investigates the antibacterial efficacy of three antimicrobial peptides, called pantinins, derived from Pandinus imperator scorpions' venom against K. pneumoniae and various KPC-producing clinical isolates.Methods Non-toxic concentrations were established for each peptide using MTT method. Antibacterial activity was performed through the liquid microdilution assay to assess the minimum inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC). A time-kill test was conducted by recording the colonies forming units (CFUs) at several times and compared with those of the untreated bacteria. Finally, the effect of peptides on the gene expression of virulence factors of K. pneumoniae was evaluated through qPCR.Results Antibacterial assays demonstrated bactericidal effects for pantinin-1 and pantinin-2 within 1 h, while pantinin-3 displayed bacteriostatic properties. Noteworthy, MIC values ranged from 6 to 25 mu M for K. pneumoniae and from 25 to 50 mu M for KPC strains. Pantinins exert their antimicrobial effect through a membranolytic mechanism, directly interacting with outer membrane lipopolysaccharides (LPS), as evidenced by circular dichroism (CD) spectra and scanning electron microscopy (SEM). In addition, qPCR showed a reduction in virulence genes expression, suggesting the antibacterial effect of peptides also at transcriptional level.Conclusion These findings support pantinins as promising candidates for treating multidrug-resistant K. pneumoniae infections.

The inhibitory potential of three scorpion venom peptides against multidrug-resistant Klebsiella pnemoniae

Monti A.;Donadio F.;Esposito E.;Doti N.;
2025

Abstract

Background The rise of drug-resistant bacterial infections, particularly those caused by Klebsiella pneumoniae underscores the urgent need for novel therapeutic candidates. Hospital-acquired infections from K. pneumoniae carbapenemase (KPC)-producing bacteria pose a serious health threat, particularly impacting the respiratory and urinary tracts. This study investigates the antibacterial efficacy of three antimicrobial peptides, called pantinins, derived from Pandinus imperator scorpions' venom against K. pneumoniae and various KPC-producing clinical isolates.Methods Non-toxic concentrations were established for each peptide using MTT method. Antibacterial activity was performed through the liquid microdilution assay to assess the minimum inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC). A time-kill test was conducted by recording the colonies forming units (CFUs) at several times and compared with those of the untreated bacteria. Finally, the effect of peptides on the gene expression of virulence factors of K. pneumoniae was evaluated through qPCR.Results Antibacterial assays demonstrated bactericidal effects for pantinin-1 and pantinin-2 within 1 h, while pantinin-3 displayed bacteriostatic properties. Noteworthy, MIC values ranged from 6 to 25 mu M for K. pneumoniae and from 25 to 50 mu M for KPC strains. Pantinins exert their antimicrobial effect through a membranolytic mechanism, directly interacting with outer membrane lipopolysaccharides (LPS), as evidenced by circular dichroism (CD) spectra and scanning electron microscopy (SEM). In addition, qPCR showed a reduction in virulence genes expression, suggesting the antibacterial effect of peptides also at transcriptional level.Conclusion These findings support pantinins as promising candidates for treating multidrug-resistant K. pneumoniae infections.
2025
Istituto di Biostrutture e Bioimmagini - IBB - Sede Napoli Via Pietro Castellino 111
Klebsiella pneumoniae
antibacterial activity
multi-drug resistant bacteria
scorpion venom peptide
synergistic action
File in questo prodotto:
File Dimensione Formato  
fmicb-16-1569719 (1).pdf

accesso aperto

Descrizione: Main text
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 3.2 MB
Formato Adobe PDF
3.2 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/559711
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact